LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 62 filers reported holding LYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,000 | -75.0% | 4,873 | +645.1% | 0.00% | – |
Q1 2024 | $4,000 | -76.5% | 654 | -80.1% | 0.00% | – |
Q4 2023 | $17,000 | +30.8% | 3,286 | +0.5% | 0.00% | – |
Q3 2023 | $13,000 | – | 3,271 | +4320.3% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 74 | -84.9% | 0.00% | – |
Q4 2022 | $2,000 | +100.0% | 491 | +210.8% | 0.00% | – |
Q3 2022 | $1,000 | – | 158 | +1655.6% | 0.00% | – |
Q2 2022 | $0 | – | 9 | -88.3% | 0.00% | – |
Q1 2022 | $0 | – | 77 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 77 | -73.2% | 0.00% | – |
Q3 2021 | $3,000 | 0.0% | 287 | -27.5% | 0.00% | – |
Q2 2021 | $3,000 | -88.0% | 396 | -82.2% | 0.00% | – |
Q1 2021 | $25,000 | -7.4% | 2,223 | -4.8% | 0.00% | – |
Q4 2020 | $27,000 | – | 2,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
Clearline Capital LP | 119,924 | $482,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |